The Patent Finder

Cristalfarma S.R.L.

7 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Oct 2038
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 19, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,005,075Supplement for Mitigating Woman's Disorders Caused by Ageing
In force
 · High confidence
In forceHigh confidence
US 11,458,160Food Supplements for Use in the Prophylaxis and Treatment of Migraine
In force
 · High confidence
In forceHigh confidence
US 11,433,109Supplement for Mitigating Woman's Disorders Caused by Ageing
In force
 · High confidence
In forceHigh confidence
US 11,045,513Association of dry extracts of Vicia faba, Uncaria rhyncophylla and liquorice root together with coenzyme Q10 for use as coadjuvant, for improving the quality of life in subjects suffering from movement disorders
In force
 · USPTO record
In forceUSPTO record
US 12,285,035Colonic release food supply as a coadjuvant in the treatment and prevention of colonic disorders caused by a suspected or confirmed alteration of the inflammatory pattern and microbiota destabilization
In force
 · USPTO record
In forceUSPTO record
US 12,324,824Food supplement, for as adjuvant, for preventing vascular dementia
In force
 · USPTO record
In forceUSPTO record
US 12,514,893A Food Supplement for Use as Coadjuvant in the Prevention and Treatment of Cognitive Decline Associated with Alzheimer Disease
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited